Balyasny Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,264
| Closed | -$1.1M | – | 2513 |
|
2025
Q1 | $1.1M | Sell |
2,264
-133,559
| -98% | -$64.8M | ﹤0.01% | 1326 |
|
2024
Q4 | $54.7M | Buy |
135,823
+81,351
| +149% | +$32.8M | 0.08% | 223 |
|
2024
Q3 | $25.3M | Buy |
54,472
+52,180
| +2,277% | +$24.3M | 0.04% | 404 |
|
2024
Q2 | $1.07M | Sell |
2,292
-185,844
| -99% | -$87.1M | ﹤0.01% | 1217 |
|
2024
Q1 | $78.6M | Buy |
188,136
+183,380
| +3,856% | +$76.7M | 0.14% | 127 |
|
2023
Q4 | $1.94M | Buy |
4,756
+873
| +22% | +$355K | ﹤0.01% | 1043 |
|
2023
Q3 | $1.35M | Buy |
3,883
+159
| +4% | +$55.3K | ﹤0.01% | 1090 |
|
2023
Q2 | $1.31M | Sell |
3,724
-35,245
| -90% | -$12.4M | ﹤0.01% | 1144 |
|
2023
Q1 | $12.3M | Buy |
38,969
+1,148
| +3% | +$362K | 0.03% | 554 |
|
2022
Q4 | $10.9M | Buy |
+37,821
| New | +$10.9M | 0.03% | 559 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 2772 |
|
2022
Q2 | – | Sell |
-19,312
| Closed | -$5.04M | – | 2738 |
|
2022
Q1 | $5.04M | Sell |
19,312
-192,035
| -91% | -$50.1M | 0.02% | 735 |
|
2021
Q4 | $46.4M | Buy |
211,347
+56,709
| +37% | +$12.5M | 0.16% | 131 |
|
2021
Q3 | $28.1M | Buy |
+154,638
| New | +$28.1M | 0.12% | 218 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 2096 |
|
2020
Q3 | – | Sell |
-4,249
| Closed | -$1.23M | – | 1390 |
|
2020
Q2 | $1.23M | Buy |
+4,249
| New | +$1.23M | 0.01% | 631 |
|
2020
Q1 | – | Sell |
-159,396
| Closed | -$34.9M | – | 1422 |
|
2019
Q4 | $34.9M | Buy |
+159,396
| New | +$34.9M | 0.21% | 134 |
|
2019
Q3 | – | Sell |
-5,043
| Closed | -$925K | – | 1453 |
|
2019
Q2 | $925K | Sell |
5,043
-14,660
| -74% | -$2.69M | 0.01% | 962 |
|
2019
Q1 | $3.62M | Sell |
19,703
-1,675
| -8% | -$308K | 0.02% | 572 |
|
2018
Q4 | $3.54M | Buy |
21,378
+5,373
| +34% | +$890K | 0.03% | 504 |
|
2018
Q3 | $3.09M | Buy |
+16,005
| New | +$3.09M | 0.01% | 676 |
|
2018
Q1 | – | Sell |
-347,312
| Closed | -$52M | – | 2046 |
|
2017
Q4 | $52M | Buy |
347,312
+155,682
| +81% | +$23.3M | 0.16% | 142 |
|
2017
Q3 | $29.1M | Sell |
191,630
-200,462
| -51% | -$30.5M | 0.11% | 211 |
|
2017
Q2 | $50.5M | Buy |
392,092
+126,175
| +47% | +$16.3M | 0.21% | 108 |
|
2017
Q1 | $29.1M | Buy |
265,917
+170,261
| +178% | +$18.6M | 0.14% | 180 |
|
2016
Q4 | $7.05M | Buy |
95,656
+5,652
| +6% | +$416K | 0.04% | 485 |
|
2016
Q3 | $7.85M | Buy |
90,004
+5,519
| +7% | +$481K | 0.05% | 429 |
|
2016
Q2 | $7.27M | Sell |
84,485
-14,225
| -14% | -$1.22M | 0.05% | 351 |
|
2016
Q1 | $7.85M | Sell |
98,710
-396,600
| -80% | -$31.5M | 0.05% | 355 |
|
2015
Q4 | $62.3M | Buy |
495,310
+426,304
| +618% | +$53.6M | 0.43% | 46 |
|
2015
Q3 | $7.19M | Buy |
+69,006
| New | +$7.19M | 0.05% | 369 |
|
2013
Q3 | – | Sell |
-55,000
| Closed | -$4.4M | – | 569 |
|
2013
Q2 | $4.4M | Buy |
+55,000
| New | +$4.4M | 0.07% | 242 |
|